Traditional Treatment for Malaria / Dysentery
Potent Anti-Viral, Anticancer, Antileukemic
Anemia, Liver Spots, Vermifugal, Diarrhea


(Simarouba amara)

Code: BOS265 -- Price: $18.50
120 Capsules x 500 mg.

Order Now Email

Summarized Description: Simarouba here refers to both "Simarouba amara" and "Simarouba glauca" as both have the same properties. Also known as Paradise Tree, Simarouba refers to a flowering tree that grows 40 to 50 feet in height and spans 25 to 30 feet. The flowers are usually yellow and the fruit elongated and purple.

Uses & Protocols
Europeans found indigenous groups in South America using Simarouba to effectively treat dysentery and malaria in the early 1700's, centuries before the rise of the pharmaceutical industry. It is also used to treat fevers, diarrhea, intestinal worms, anemia, and indigestion. Owning to its strong anti-viral properties, Simarouba has been shown in multiple studies to be effective in vitro against herpes, influenza, polio, and vaccinia viruses. (The field is still in need of well-constructed anti-viral studies, in vivo.)
Taylor reports that the National Cancer Institute performed early cancer screenings in 1976, showing that Simarouba was toxic against cancer cells at very low dosages. What followed were further studies showing this plant's antileukemic action.
Lastly, Simarouba is being used for topical applications for skin depigmentation (i.e. liver spots) and keratinocyte differentiation (protecting against scaly skin.)
Dosage: one capsule, two times a day.

Warnings & Contraindications
None reported where taken at normal, therapeutic dosages. In higher than recommended dosages, nausea and vomiting may result. There are no reported drug contraindications.

Five years or more.

James Duke's Handbook of Medical Plants of Latin America
Medicinal Activities
Further information for practitioners: World-famous botanist Dr. James Duke attributes the following activities to this plant (p. 638-639; see hardcopy cover at right), drawn from the extant literature. (See his graduation for "level of efficacy" on our amazon traditionals page; followed by Duke's bibliographic abbreviations (in capital letters), which we identify on a separate page.)
Duke provides a "food farmacy potential" score for this plant of "FNFF=!."

  • Amebicide (f1; MAX; RAI; TRA)
  • Analgesic (f1; AHL; AUS; RAI)
  • Anticancer (1; X15852485)
  • Antileukemic (f; AUS)
  • Antimalarial (f1; IED; JFM; X9210673)
  • AntiMDR (1; RAI)
  • Antiseptic (1; AUS; RAI)
  • Antitumor (1; RAI)
  • Antiviral (1; RAI)
  • Astringent (1; AAB)
  • Bactericide (1; AUS; RAI; X2214824)
  • Bronchoconstrictor (1; TRA)\
  • Choleretic (f; DLZ)
  • Cytotoxic (1; X15852485; X9210673)
  • Diaphoretic (1; RAI)
  • Diuretic (f; RAI)
  • Emetic (f; AUS)
  • Febrifuge (f1; MAX; RAI)
  • Hemostat (1; RAI)
  • Insecticide (1; TRA)
  • Locusticide (1; TRA)
  • Parasiticide (1; RAI)
  • Pediculicide (1; TRA)
  • Purgative (f; AUS)
  • Stomachic (f; AUS; JFM; MAX)
  • Sudorific (f; AHL, AUS)
  • Tonic (1; RAI; TRA)
  • Vermifuge (f1; AUS; RAI)

Further information for practitioners: Duke provides the following indications for this plant:
  • Amenorrhea (f1; AHL; RAI)
  • Anemia (f; AHL; RAI)
  • Bacteria (1; AUS; RAI; X2214824)
  • Biliousness (f; DLZ)
  • Bleeding (f1; AUS; RAI)
  • Cancer (1; X15852485)
  • Colic (f; AHL; RAI)
  • Colitis (f1; RAI)
  • Dermatosis (f; TRA)
  • Diarrhea (f1; AAB; AHL; JFM: RAI)
  • Dysentery (f1; AAB; AHL; RAI)
  • Dysmenorrhea (f; AUS; RAI)
  • Dyspepsia (f; AHL; MAX; RAI)
  • Enterosis (f; RAI)
  • Fever (f1; JFM; MAX; RAI)
  • Gastrosis (f1; AUS; RAI; TRA)
  • Gonorrhea (f; AHL)
  • Hemorrhage (1; AAB)
  • Hepatosis (f; DLZ)
  • Herpes (1; RAI)
  • Infection (1; AUS; RAI; X2214824)
  • Itch (f; TRA)
  • Leukemia (f1; AUS; RAI)
  • Liver Spots (f; RAI)
  • Malaria (fl; IED; JFM; RAI; TRA; X9210673)
  • MDR (l; RAI)
  • Metrorrhagia (l; AAB)
  • Pain (fl; AHL; AUS; RAI)
  • Parasites (l; RAI)
  • Pediculosis (fl; TRA)
  • Polio (l; RAI)
  • Rashes (f; TRA)
  • Rheumatism (f; AHL)
  • Salmonella (1; RAI; TRA)
  • Sarcptosis (1' TRA)
  • Scabies (l; TRA)
  • Shigella (l; RAI; TRA)
  • Sores (fl; AAB; AUS; RAI)
  • Tumors (l; RAI)
  • Ulcers (l; TRA)
  • Vaccinia (l; RAI)
  • VD (f; AHL; RAI)
  • Viruses (1; RAI)
  • West Nile (f; RAI)
  • Whitener (1; RAI)
  • Worms (f1; AUS; RAI)
  • Wounds (f; RAI)

To U.S. Users: This product have not been evaluated by the U.S. Food & Drug Administration. It is not intended to diagnose, treat, cure, or prevent any disease.

Recent Studies on Simarouba
Sourced from PubMed
Disclaimer: The following citations provide findings on the properties of Simarouba and offer insights into prospective areas of future research. These findings should not be inferred to provide the basis of medicinal claims, nor should they be relied upon by the public, as such. Readers who want full access to the PubMed database are encouraged to register with NCBI.
As of Jan. 2017, there were 44 citations covering this botanical. Below we list a few of the more notable:

Extensive information about Simarouba is covered on the Raintree Forest website. Even better, you can purchase Leslie Taylor's excellent reference book, The Healing Power of Rainforest Herbs: A Guide to Understanding and Using Herbal Medicinals at Amazon.
Simarouba amara and Simarouba glauca are covered separate in Wikipedia.